Development and clinical validation of a novel biopsy-based six-gene signature to accurately risk-stratify men with early-stage prostate cancer to aid treatment decision making.

被引：0
|
作者：
Krzyzanowska, Agnieszka
Barron, Stephen
Higgins, Debra
Loughman, Tony
Sheehan, Katherine
Wang, Angel Chan-Ju
Fender, Bozena
McGuire, Leah M.
Galvin, David Jonathan
O'Neill, Amanda
Fay, Joanna
O'Grady, Anthony
O'Leary, Des
Watson, William
Bjartell, Anders
Gallagher, William M.
机构：
[1] Lund Univ, Div Urol Cancers, Fac Med, Lund, Sweden
[2] OncoAssure Ltd, Dublin, Ireland
[3] RCSI Educ & Res Ctr, Dublin, Ireland
[4] St Vincents Hosp Grp, Dublin, Ireland
[5] Univ Coll Dublin, Dublin, Ireland
[6] Beaumont Hosp, Dept Histopathol, Dublin, Ireland
[7] OncoAssure Ltd, Dublin, Ireland
[8] Sch Med & Med Sci, Dublin, Ireland
[9] Skane Univ Hosp, Malmo, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
374
引用
收藏
页数：1
相关论文
共 11 条
  • [1] Development and validation of a novel six-gene signature to accurately risk stratify men with early-stage prostate cancer to aid in treatment decision making
    Krzyzanowska, A.
    Barron, S.
    Loughman, T.
    Higgins, D. F.
    Sheehan, K. M.
    Wang, A. Chan-Ju
    Fender, B.
    McGuire, L. M.
    O'Neill, A.
    Fay, J.
    O'Grady, T.
    O'Leary, D.
    Bjartell, A.
    Watson, R. W. G.
    Gallagher, W. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1190 - S1190
  • [2] Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer
    Krzyzanowska, Agnieszka
    Higgins, Debra F.
    Barron, Stephen
    Loughman, Tony
    O'Neill, Amanda
    Sheehan, Katherine M.
    Wang, Chan-Ju Angel
    Fender, Bozena
    Mcguire, Leah
    Fay, Joanna
    O'Grady, Anthony
    O'Leary, Des
    Watson, R. William
    Bjartell, Anders
    Gallagher, William M.
    BJUI COMPASS, 2025, 6 (01):
  • [3] Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
    Liu, Zaoqu
    Lu, Taoyuan
    Li, Jing
    Wang, Libo
    Xu, Kaihao
    Dang, Qin
    Guo, Chunguang
    Liu, Long
    Jiao, Dechao
    Sun, Zhenqiang
    Han, Xinwei
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [4] Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
    Zaoqu Liu
    Taoyuan Lu
    Jing Li
    Libo Wang
    Kaihao Xu
    Qin Dang
    Chunguang Guo
    Long Liu
    Dechao Jiao
    Zhenqiang Sun
    Xinwei Han
    Cancer Cell International, 21
  • [5] CLINICAL VALIDATION OF A NOVEL SIX-GENE RISK-STRATIFICATION SIGNATURE TO SUPPORT TREATMENT DECISIONS FOR MEN DIAGNOSED WITH PROSTATE CANCER
    Krzyzanowska, Agnieszka
    Barron, Stephen
    Higgins, Debra F.
    Loughman, Tony
    Sheehan, Katherine M.
    Wang, Angel Chan-Ju
    Fender, Bozena
    McGuire, Leah M.
    Galvin, David
    O'Neil, Amanda
    Fay, Joanna
    O'Grady, Anthony
    O'Leary, Desmond
    Watson, R. William. G.
    Bjartell, Anders
    Gallagher, William M.
    JOURNAL OF UROLOGY, 2023, 209 : E215 - E215
  • [6] Clinical validation of a mesenchymal gene expression signature for prognosis and treatment decision making in early-stage oral cavity squamous cell carcinoma
    Hayes, David N.
    Mayhew, Gregory
    Uronis, Joshua M.
    Zevallos, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Impact of a novel decision counseling program on treatment knowledge, decisional conflict, and choice in men with early-stage, low-risk prostate cancer
    Hoffman-Censits, Jean H.
    Petrich, Anett
    Quinn, Anna
    Leader, Amy
    Gomella, Leonard G.
    Dicker, Adam
    Den, Robert Benjamin
    Hurwitz, Mark
    Kelly, William Kevin
    Lallas, Costas D.
    Burns, Katherine
    Trabulsi, Edouard John
    Myers, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [8] Cost-effectiveness of a biopsy-based 8-protein prognostic assay to optimize treatment decisions in intermediate-risk early-stage prostate cancer.
    Roth, Joshua A.
    Ramsey, Scott David
    Carlson, Josh John
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [9] Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial
    Cuypers, Maarten
    Lamers, Romy E. D.
    Kil, Paul J. M.
    van de Poll-Franse, Lonneke V.
    de Vries, Marieke
    TRIALS, 2015, 16
  • [10] Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial
    Maarten Cuypers
    Romy E. D. Lamers
    Paul J. M. Kil
    Lonneke V. van de Poll-Franse
    Marieke de Vries
    Trials, 16
12